Mirion Tech Q1: Nuclear & Medical Segments Soar

Mirion Technologies kicked off 2026 with robust first quarter results, boasting a 19% surge in orders to $241 million (42% including M&A) and a 28% revenue increase to $258 million. Adjusted EBITDA rose 16% to $54 million, and backlog now stands at $1.1 billion. Nuclear power drove growth in their Nuclear and Safety segment, with acquisitions like Paragon adding $43 million in orders. The Medical segment also showed promise, with 4% organic revenue growth and double-digit gains in radiation therapy quality assurance. Mirions integrated solutions position them well for revenue acceleration as orders convert, particularly in the global nuclear revival. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ab239ca987f0f2b1